These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 10806614)

  • 1. Characterization of Smad phosphorylation and Smad-receptor interaction.
    Mehra A; Attisano L; Wrana JL
    Methods Mol Biol; 2000; 142():67-78. PubMed ID: 10806614
    [No Abstract]   [Full Text] [Related]  

  • 2. Defective transforming growth factor beta signaling pathway in head and neck squamous cell carcinoma as evidenced by the lack of expression of activated Smad2.
    Muro-Cacho CA; Rosario-Ortiz K; Livingston S; Muñoz-Antonia T
    Clin Cancer Res; 2001 Jun; 7(6):1618-26. PubMed ID: 11410498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Smad-binding defective mutant of transforming growth factor beta type I receptor enhances tumorigenesis but suppresses metastasis of breast cancer cell lines.
    Tian F; Byfield SD; Parks WT; Stuelten CH; Nemani D; Zhang YE; Roberts AB
    Cancer Res; 2004 Jul; 64(13):4523-30. PubMed ID: 15231662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J; Dai C; Liu Y
    J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Signal transduction. An anchor for activation.
    ten Dijke P; Heldin CH
    Nature; 1999 Jan; 397(6715):109, 111. PubMed ID: 9923670
    [No Abstract]   [Full Text] [Related]  

  • 7. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors.
    Goumans MJ; Valdimarsdottir G; Itoh S; Rosendahl A; Sideras P; ten Dijke P
    EMBO J; 2002 Apr; 21(7):1743-53. PubMed ID: 11927558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling.
    Goto D; Nakajima H; Mori Y; Kurasawa K; Kitamura N; Iwamoto I
    Biochem Biophys Res Commun; 2001 Mar; 281(5):1100-5. PubMed ID: 11243848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of activin receptor-like kinase 5 signaling blocks profibrotic transforming growth factor beta responses in skin fibroblasts.
    Mori Y; Ishida W; Bhattacharyya S; Li Y; Platanias LC; Varga J
    Arthritis Rheum; 2004 Dec; 50(12):4008-21. PubMed ID: 15593186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta induced collagenase-3 production in human osteoarthritic chondrocytes is triggered by Smad proteins: cooperation between activator protein-1 and PEA-3 binding sites.
    Tardif G; Reboul P; Dupuis M; Geng C; Duval N; Pelletier JP; Martel-Pelletier J
    J Rheumatol; 2001 Jul; 28(7):1631-9. PubMed ID: 11469472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
    Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
    J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling.
    Suh N; Roberts AB; Birkey Reffey S; Miyazono K; Itoh S; ten Dijke P; Heiss EH; Place AE; Risingsong R; Williams CR; Honda T; Gribble GW; Sporn MB
    Cancer Res; 2003 Mar; 63(6):1371-6. PubMed ID: 12649201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of Smad nucleocytoplasmic shuttling in living cells.
    Nicolás FJ; De Bosscher K; Schmierer B; Hill CS
    J Cell Sci; 2004 Aug; 117(Pt 18):4113-25. PubMed ID: 15280432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alteration of the TGF-beta/SMAD pathway in intrinsically and UV-induced skin aging.
    Han KH; Choi HR; Won CH; Chung JH; Cho KH; Eun HC; Kim KH
    Mech Ageing Dev; 2005 May; 126(5):560-7. PubMed ID: 15811425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin.
    Glister C; Kemp CF; Knight PG
    Reproduction; 2004 Feb; 127(2):239-54. PubMed ID: 15056790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel dominant negative Smad2 mutation in a TGFbeta resistant human carcinoma cell line.
    Tsang KJ; Tsang D; Brown TN; Crowe DL
    Anticancer Res; 2002; 22(1A):13-9. PubMed ID: 12017275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TGF-beta3-dependent SMAD2 phosphorylation and inhibition of MEE proliferation during palatal fusion.
    Cui XM; Chai Y; Chen J; Yamamoto T; Ito Y; Bringas P; Shuler CF
    Dev Dyn; 2003 Jul; 227(3):387-94. PubMed ID: 12815624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Semisynthesis of phosphovariants of Smad2 reveals a substrate preference of the activated T beta RI kinase.
    Ottesen JJ; Huse M; Sekedat MD; Muir TW
    Biochemistry; 2004 May; 43(19):5698-706. PubMed ID: 15134444
    [TBL] [Abstract][Full Text] [Related]  

  • 19. From receptor to nucleus: the Smad pathway.
    Baker JC; Harland RM
    Curr Opin Genet Dev; 1997 Aug; 7(4):467-73. PubMed ID: 9309176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular signaling: Fleshing out the TGFbeta pathway.
    Padgett RW
    Curr Biol; 1999 Jun; 9(11):R408-11. PubMed ID: 10359694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.